InsidersTradesSigma
Nuo Therapeutics, Inc.: directors' dealings · United States · SEC (Form 4)
SEC:nuo-therapeutics-inc-8caa62US·SEC (Form 4)Mcap 60M€Healthcare
Explore the full insider trade history of Nuo Therapeutics, Inc., a publicly traded company based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Operating in the Healthcare sector, Nuo Therapeutics, Inc. has logged 4 public disclosures. Market capitalisation: €60.4m. The latest transaction was disclosed on 2 May 2022 — Attribution. Among the most active insiders: Pittman Scott M.. All data is free.
4
Insider Decl.
0
Thresholds
€766,234
1 ops.
Buy Volume
·
0 ops.
Sell Volume
Financial data
FY ended December 2025 · cache
1.25 €
Analyst consensus
Income statement
Revenue3.3 M€
Gross profit2.2 M€67% margin
Net income−2.5 M€-75.8% margin
Balance sheet & cash
Market cap60.4 M€
Total debt597 k€
Free Cash Flow−1.1 M€
Profitability & ownership
% insiders57.9%
% institutions2.1%
Last declaration on 2 May 2022
Declarations4 total
Executives◆Grant28SEC
€95,200100,000 shares@ €0.9520.16% mcap100.0% of flow
Common Stock
SEC:0001437749-22-010379:0·
Executives◆Grant24SEC
€23,80025,000 shares@ €0.9520.039% mcap100.0% of flow
Common Stock
SEC:0001437749-22-010381:0·
Executives◆Grant36SEC
€10,02610,532 shares@ €0.9520.017% mcap100.0% of flow
Common Stock
SEC:0001437749-22-010382:0·
Executives▲Purchase28SEC
€766,234804,868 shares@ €0.9521.27% mcap100.0% of flow
Common Stock
SEC:0001437749-22-010378:0·
Ideal exit: 24 Jan 2023 (T+270)
4 of 4 declarations